These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 2980988

  • 21. Placental transfer and developmental effects of 9-cis retinoic acid in mice.
    Kochhar DM, Jiang H, Penner JD, Heyman RA.
    Teratology; 1995 Apr; 51(4):257-65. PubMed ID: 7570368
    [Abstract] [Full Text] [Related]

  • 22. Limb bud cell cultures for estimating the teratogenic potential of compounds. Validation of the test system with retinoids.
    Kistler A.
    Arch Toxicol; 1987 Aug; 60(6):403-14. PubMed ID: 2444191
    [Abstract] [Full Text] [Related]

  • 23. Inefficacy of the synthetic aromatic retinoid etretinate and of its free acid on the in-vitro differentiation of leukemic cells.
    Chomienne C, Balitrand N, Abita JP.
    Leuk Res; 1986 Aug; 10(9):1079-81. PubMed ID: 2945054
    [Abstract] [Full Text] [Related]

  • 24. Comparative teratology and transplacental pharmacokinetics of all-trans-retinoic acid, 13-cis-retinoic acid, and retinyl palmitate following daily administrations in rats.
    Collins MD, Tzimas G, Hummler H, Bürgin H, Nau H.
    Toxicol Appl Pharmacol; 1994 Jul; 127(1):132-44. PubMed ID: 8048045
    [Abstract] [Full Text] [Related]

  • 25. Induction of beta-retinoic acid receptor mRNA by teratogenic doses of retinoids in murine fetuses.
    Harnish DC, Barua AB, Soprano KJ, Soprano DR.
    Differentiation; 1990 Nov; 45(2):103-8. PubMed ID: 1965892
    [Abstract] [Full Text] [Related]

  • 26. Pharmacokinetic profile of two aromatic retinoids (etretinate and acitretin) in the obese Zucker rat.
    McNamara PJ, Blouin RA.
    J Pharm Sci; 1990 Apr; 79(4):301-4. PubMed ID: 2141075
    [Abstract] [Full Text] [Related]

  • 27. [Pharmacokinetics of etretinate, acitretin and 13-cis-acitretin: new results and advantages of blood level oriented clinical use].
    Gollnick H, Rinck G, Bitterling T, Orfanos CE.
    Z Hautkr; 1990 Jan; 65(1):40-50. PubMed ID: 2139274
    [Abstract] [Full Text] [Related]

  • 28. Systemic pharmacokinetics of acitretin, etretinate, isotretinoin, and acetylenic retinoids in guinea pigs and obese rats.
    Chien DS, Sandri RB, Tang-Liu DS.
    Drug Metab Dispos; 1992 Jan; 20(2):211-7. PubMed ID: 1352212
    [Abstract] [Full Text] [Related]

  • 29. The area under the concentration-time curve of all-trans-retinoic acid is the most suitable pharmacokinetic correlate to the embryotoxicity of this retinoid in the rat.
    Tzimas G, Thiel R, Chahoud I, Nau H.
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):436-44. PubMed ID: 9144460
    [Abstract] [Full Text] [Related]

  • 30. Correlation of transplacental and maternal pharmacokinetics of retinoids during organogenesis with teratogenicity.
    Nau H.
    Methods Enzymol; 1990 Apr; 190():437-48. PubMed ID: 2150873
    [No Abstract] [Full Text] [Related]

  • 31. Teratogenesis and reproductive safety evaluation of the retinoid etretin (Ro 10-1670).
    Kistler A, Hummler H.
    Arch Toxicol; 1985 Oct; 58(1):50-6. PubMed ID: 2934041
    [Abstract] [Full Text] [Related]

  • 32. Selective agonists of retinoic acid receptors: comparative toxicokinetics and embryonic exposure.
    Arafa HM, Elmazar MM, Hamada FM, Reichert U, Shroot B, Nau H.
    Arch Toxicol; 2000 Jan; 73(10-11):547-56. PubMed ID: 10663386
    [Abstract] [Full Text] [Related]

  • 33. The high sensitivity of the rabbit to the teratogenic effects of 13-cis-retinoic acid (isotretinoin) is a consequence of prolonged exposure of the embryo to 13-cis-retinoic acid and 13-cis-4-oxo-retinoic acid, and not of isomerization to all-trans-retinoic acid.
    Tzimas G, Bürgin H, Collins MD, Hummler H, Nau H.
    Arch Toxicol; 1994 Jan; 68(2):119-28. PubMed ID: 8179481
    [Abstract] [Full Text] [Related]

  • 34. Differential teratogenic response of mouse embryos to receptor selective analogs of retinoic acid.
    Kochhar DM, Jiang H, Penner JD, Beard RL, ChandraratnaAS.
    Chem Biol Interact; 1996 Mar 08; 100(1):1-12. PubMed ID: 8599851
    [Abstract] [Full Text] [Related]

  • 35. In-vitro teratogenicity of retinoids.
    Steele CE, Marlow R, Turton J, Hicks RM.
    Br J Exp Pathol; 1987 Apr 08; 68(2):215-23. PubMed ID: 3580281
    [Abstract] [Full Text] [Related]

  • 36. Acitretin versus etretinate in severe psoriasis. A double-blind randomized Nordic multicenter study in 168 patients.
    Bjerke JR, Geiger JM.
    Acta Derm Venereol Suppl (Stockh); 1989 Apr 08; 146():206-7. PubMed ID: 2532847
    [Abstract] [Full Text] [Related]

  • 37. Etretinate pharmacokinetics in chronic renal failure. A preliminary study in psoriasis patients.
    Vahlquist A.
    Dermatologica; 1987 Apr 08; 175(5):224-8. PubMed ID: 2960573
    [Abstract] [Full Text] [Related]

  • 38. Structure-activity relationships of retinoids in developmental toxicology. III. Contribution of the vitamin A beta-cyclogeranylidene ring.
    Howard WB, Willhite CC, Dawson MI, Sharma RP.
    Toxicol Appl Pharmacol; 1988 Aug 08; 95(1):122-38. PubMed ID: 3413791
    [Abstract] [Full Text] [Related]

  • 39. Effects of isotretinoin (13-cis-retinoic acid) on the development of mouse limbs in vivo and in vitro.
    Kwasigroch TE, Bullen M.
    Teratology; 1991 Dec 08; 44(6):605-16. PubMed ID: 1805431
    [Abstract] [Full Text] [Related]

  • 40. Comparative teratogenic activity of cancer chemopreventive retinoidal benzoic acid congeners (arotinoids).
    Flanagan JL, Willhite CC, Ferm VH.
    J Natl Cancer Inst; 1987 Mar 08; 78(3):533-8. PubMed ID: 3469465
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.